ARTICLE | Company News
Abcodia, Biouniversa deal
April 30, 2012 7:00 AM UTC
The companies partnered to develop Biouniversa's Biouniversa BCL2-associated athanogene 3 ( BAG3; CAIR-1) ELISA assay technology to detect pancreatic cancer in asymptomatic individuals and at the ea...